- Home
- SNOW vs BMY Comparison
SNOW vs BMY Comparison
Compare SNOW & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNOW | BMY |
|---|---|---|
| Founded | 2012 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.9B | 113.5B |
| IPO Year | 2020 | 2006 |
Fundamental Metrics
Financial Performance| Metric | SNOW | BMY |
|---|---|---|
| Price | $341.23 | $61.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 52 | 28 |
| Target Price | ★ $425.14 | $66.71 |
| AVG Volume (30 Days) | 4.6M | ★ 8.4M |
| Earning Date | 09-02-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 4.04% |
| EPS Growth | N/A | ★ 178.46 |
| EPS | N/A | ★ 2.93 |
| Revenue | $4,683,946,000.00 | ★ $48,194,000,000.00 |
| Revenue This Year | $34.83 | $3.42 |
| Revenue Next Year | $28.47 | N/A |
| P/E Ratio | ★ N/A | $21.67 |
| Revenue Growth | ★ 29.16 | N/A |
| 52 Week Low | $118.30 | $42.52 |
| 52 Week High | $384.56 | $68.64 |
Technical Indicators
Market Signals| Indicator | SNOW | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 54.71 | 42.40 |
| Support Level | $317.45 | $56.46 |
| Resistance Level | $345.28 | $62.39 |
| Average True Range (ATR) | 12.84 | 1.24 |
| MACD | -0.81 | -0.10 |
| Stochastic Oscillator | 64.85 | 36.10 |
Price Performance
Historical ComparisonAbout SNOW Snowflake Inc.
Founded in 2012, Snowflake is a fully managed platform that consolidates data hosted on different public clouds for centralized analytics and governance. Snowflake's cloud-native architecture allows users to independently scale the compute and storage layers, providing customers with optimized performance at lower costs. The company's data lake and data warehouse products support a variety of use cases, including business analytics, data engineering, and artificial intelligence. Snowflake is widely used by Fortune 2000 companies in financial services, media, and retail sectors.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.